Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
VPN Administrations for Online Protection - 2Which European countries have mandatory or voluntary military service
- 3Glamour Shots once ruled the mall. I went to one of the last ones standing.
- 4I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites.
- 5The most effective method to Guarantee Simple Availability in Seniors' SUVs
- This Tiny Neon Frog Dwells in the Clouds
- Triple polar vortex to plunge central and eastern U.S. into Arctic cold through mid-December
- Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- Middle East hotels hit pandemic-era lows amid Iran war
- Scientists Just Discovered Japan’s First New Bird Species in Over 40 Years
- Former hostage Eitan Mor on Hamas: ‘They will not give up until the last Israeli is gone'
- Oil Tanker Carrying Iraqi Cargo Seen Transiting Strait of Hormuz
- Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- 'Senseless violence' erupts at Christmas tree lighting; 4 injured
